World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
48319
World Ranking
580
National Ranking
345

Medicine

D-Index
105
Citations
48384
World Ranking
6704
National Ranking
3539

David H. Munn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David H. Munn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 299 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David H. Munn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David H. Munn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David H. Munn is affiliated with Augusta University in the United States. Their research primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these domains, their work is further specialized in Immunology, Oncology, Molecular Biology, Genetics, and Neurology.

The scientist has contributed extensively to topics related to immune cell function and interaction, cancer immunotherapy and biomarkers, immunotherapy and immune responses, immune cells in cancer, glioma diagnosis and treatment, CAR-T cell therapy research, and adenosine and purinergic signaling.

Frequent publication venues for their research include Neuro-Oncology, the Journal for ImmunoTherapy of Cancer, The Journal of Immunology, Cancer Cell, and Blood.

Their recent papers include the following:

  • The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling, 2020, Immunity
  • CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint, 2020, Nature Communications
  • Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses, 2022, Cancer Cell
  • Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma, 2020, Clinical Cancer Research
  • Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment, 2023, Cancer Cell

Among the frequent co-authors collaborating with David H. Munn are Rafał Pacholczyk, Ramses Sadek, Theodore S. Johnson, Eugene P. Kennedy, and Zuzana Berrong.

Best Publications

  • Prevention of allogeneic fetal rejection by tryptophan catabolism

    David H. Munn;Min Zhou;John T. Attwood;Igor Bondarev

  • IDO expression by dendritic cells: tolerance and tryptophan catabolism.

    Andrew L. Mellor;David H. Munn

  • Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

    Nagendra Singh;Ashish Gurav;Sathish Sivaprakasam;Evan Brady

  • INHIBITION OF T CELL PROLIFERATION BY MACROPHAGE TRYPTOPHAN CATABOLISM

    David H. Munn;Ebrahim Shafizadeh;John T. Attwood;Igor Bondarev

  • GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

    David H. Munn;Madhav D. Sharma;Babak Baban;Heather P. Harding

  • Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

    David H. Munn;Madhav D. Sharma;Jeffrey R. Lee;Kanchan G. Jhaver

  • Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

    David H. Munn;Andrew L. Mellor

  • Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

    David H. Munn;Madhav D. Sharma;Deyan Hou;Babak Baban

  • Indoleamine 2,3 dioxygenase and metabolic control of immune responses

    David H. Munn;Andrew L. Mellor

  • IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

    David H. Munn;Andrew L. Mellor

  • Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

    Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou

  • Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

    Andrew L Mellor;David H Munn

  • Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

    Qing Zhou;Meghan E. Munger;Rachelle G. Veenstra;Brenda J. Weigel

  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

    Rikke B. Holmgaard;Dmitriy Zamarin;David H. Munn;Jedd D. Wolchok;Jedd D. Wolchok;Jedd D. Wolchok

  • Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses

    De Yan Hou;Alexander J. Muller;Madhav D. Sharma;James DuHadaway

  • Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells

    David H. Munn;Madhav D. Sharma;Andrew L. Mellor

  • Immune suppressive mechanisms in the tumor microenvironment.

    David H Munn;Vincenzo Bronte

  • The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation

    Wei Chen;Xueqing Liang;Amanda J. Peterson;David H. Munn

  • Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion

    Andrew L. Mellor;Babak Baban;Phillip Chandler;Brendan Marshall

  • IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells

    Babak Baban;Phillip R. Chandler;Madhav D. Sharma;Jeanene Pihkala

  • Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

    Andrew L. Mellor;Jayabalan Sivakumar;Phillip Chandler;Kimberly Smith

Frequent Co-Authors

Andrew L. Mellor
Andrew L. Mellor Newcastle University
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Angela Panoskaltsis-Mortari
Angela Panoskaltsis-Mortari University of Minnesota
Jonathan S. Serody
Jonathan S. Serody University of North Carolina at Chapel Hill
William J. Murphy
William J. Murphy Texas A&M University
Huidong Shi
Huidong Shi Augusta University
Patricia A. Taylor
Patricia A. Taylor University of Minnesota
Ivan Maillard
Ivan Maillard University of Pennsylvania
George C. Prendergast
George C. Prendergast Lankenau Institute for Medical Research
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can offer diverse career opportunities. Accelerated nursing programs provide a fast-track path into nursing, making them ideal for individuals who want to quickly build clinical skills while supporting patient care related to immune health. You can find options that balance speed with quality through accelerated nursing programs.

Similarly, entering the workforce as a Licensed Practical Nurse (LPN) can be an efficient starting point. Many lpn programs easy to get into offer flexible schedules and foundational training, which complement further specialization in immunologic or infectious diseases.

Nurses aiming to expand their scope of practice might choose to pursue advanced degrees such as nurse practitioner programs. The easiest online nurse practitioner programs enable working professionals to study while maintaining their career, focusing on holistic patient care including immune system-related conditions.

For those passionate about mental health and immunology’s role in psychiatric conditions, programs like the best pmhnp programs offer specialized training with excellent clinical placements, preparing graduates to impact patient outcomes in this growing field.

Best Scientists Citing David H. Munn

Trending Scientists

Recently Published Articles